{"title":"Industrial–scale production of various bio–commodities by engineered microbial cell factories: Strategies of engineering in microbial robustness","authors":"Ju-Hyeong Jung , Vinoth Kumar Ponnusamy , Gopalakrishnan Kumar , Bartłomiej Igliński , Vinod Kumar , Grzegorz Piechota","doi":"10.1016/j.cej.2024.157679","DOIUrl":null,"url":null,"abstract":"<div><div>The utilization of renewable, non–edible biomass for synthesis of valuable bio–products including bio–fuels, bio-chemicals and bio–polymeric materials, in an environmentally sustainable manner is crucial for addressing the urgent environmental challenges caused by our substantial dependence on fossil fuel resources. In this context, engineered microbial cell factories (MCFs), which are the modified microorganisms, have gained attention and provide biosynthetically optimized pathways for the production of desired bio–commodities using renewable carbon sources. Biosynthetic routes for the production of such bio–commodities can be categorized into three groups based on the chosen microbial host for genetic modification: native, non–native, and artificial pathways. Engineered MCFs are increasingly essential in the pharmaceutical, food, and bio–chemical industries and are being developed to address the growing world population and socioeconomic crisis. Mainly, microorganisms have been utilized in the manufacturing of a range of bio–products including amino acids, carboxylic acids, carotenoids, enzymes, vitamins, plant natural products, biogas, and other biofuels. Furthermore, the implementation of advanced metabolic engineering and synthetic biology tools & techniques enhances the speed, concentration, and efficiency of commercially important substances by modifying the metabolism, carbon–energy balance and eliminating an undesired ATP sink, physiology, and stress response. All these has resulted in rapid growth of industrial biotechnology for production of several bio–commodities. Further, the scale and numbers of bio–commodities is increasing with time. This review summarizes the design of MFCs, selection of microbial strains, metabolic pathways, engineered MCFs for industrial–scale applications, strategies for engineering microbial robustness, commercial restrictions, and their future prospects.</div></div>","PeriodicalId":270,"journal":{"name":"Chemical Engineering Journal","volume":"502 ","pages":"Article 157679"},"PeriodicalIF":13.3000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1385894724091708","RegionNum":1,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, CHEMICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The utilization of renewable, non–edible biomass for synthesis of valuable bio–products including bio–fuels, bio-chemicals and bio–polymeric materials, in an environmentally sustainable manner is crucial for addressing the urgent environmental challenges caused by our substantial dependence on fossil fuel resources. In this context, engineered microbial cell factories (MCFs), which are the modified microorganisms, have gained attention and provide biosynthetically optimized pathways for the production of desired bio–commodities using renewable carbon sources. Biosynthetic routes for the production of such bio–commodities can be categorized into three groups based on the chosen microbial host for genetic modification: native, non–native, and artificial pathways. Engineered MCFs are increasingly essential in the pharmaceutical, food, and bio–chemical industries and are being developed to address the growing world population and socioeconomic crisis. Mainly, microorganisms have been utilized in the manufacturing of a range of bio–products including amino acids, carboxylic acids, carotenoids, enzymes, vitamins, plant natural products, biogas, and other biofuels. Furthermore, the implementation of advanced metabolic engineering and synthetic biology tools & techniques enhances the speed, concentration, and efficiency of commercially important substances by modifying the metabolism, carbon–energy balance and eliminating an undesired ATP sink, physiology, and stress response. All these has resulted in rapid growth of industrial biotechnology for production of several bio–commodities. Further, the scale and numbers of bio–commodities is increasing with time. This review summarizes the design of MFCs, selection of microbial strains, metabolic pathways, engineered MCFs for industrial–scale applications, strategies for engineering microbial robustness, commercial restrictions, and their future prospects.
期刊介绍:
The Chemical Engineering Journal is an international research journal that invites contributions of original and novel fundamental research. It aims to provide an international platform for presenting original fundamental research, interpretative reviews, and discussions on new developments in chemical engineering. The journal welcomes papers that describe novel theory and its practical application, as well as those that demonstrate the transfer of techniques from other disciplines. It also welcomes reports on carefully conducted experimental work that is soundly interpreted. The main focus of the journal is on original and rigorous research results that have broad significance. The Catalysis section within the Chemical Engineering Journal focuses specifically on Experimental and Theoretical studies in the fields of heterogeneous catalysis, molecular catalysis, and biocatalysis. These studies have industrial impact on various sectors such as chemicals, energy, materials, foods, healthcare, and environmental protection.